TY - JOUR
T1 - Adenosine A2A receptors interact with GABAergic pathways to modulate respiration in neonatal piglets
AU - Wilson, Christopher G.
AU - Martin, Richard J.
AU - Jaber, Marwan
AU - Abu-Shaweesh, Jalal
AU - Jafri, Anjun
AU - Haxhiu, Musa A.
AU - Zaidi, Syed
N1 - Funding Information:
The authors would like to thank Drs. M. Miller and T.E. Dick for critical comments and stimulating discussion during the course of this work. This work was supported by the National Institutes of Health (HL 62527 and IU 54 NS 39407).
PY - 2004/7/20
Y1 - 2004/7/20
N2 - GABA and adenosine contribute to respiratory inhibition in early postnatal life. In this study the adenosine A2A receptor agonist CGS21680 was used to evaluate adenosine receptor specificity and the interrelation of adenosine and GABA in the inhibition of inspiratory drive. In neonatal piglets (n = 10), CGS21680 was injected into the fourth ventricle resulting in apnea and/or decreased burst area and frequency of phrenic discharge. Phrenic burst area decreased to 58.9 ± 8.6% (S.E.M.) after CGS21680 injection (control = 91.8 ± 1.0%). Expiratory time increased 261.0 ± 59.9% after CGS21680 from control (87.7 ± 2.7%). When bicuculline was injected locally within the rostral ventrolateral medulla (n = 5), or into the fourth ventricle (n = 5), the CGS21680 induced inhibition of phrenic was abolished. To define expression of A2A receptor at the message level (mRNA), we employed in situ hybridization with a digoxigenin-coupled oligonucleotide. Adenosine A2A receptor mRNA was expressed in regions of the medulla oblongata known to contain GABAergic neurons. We conclude that GABAergic inputs affecting respiratory timing and inspiratory drive are modulated by activation of A2A receptors. These findings offer new insight into the mechanism whereby xanthine therapy diminishes apnea of prematurity. © 2004 Elsevier B.V. All rights reserved.
AB - GABA and adenosine contribute to respiratory inhibition in early postnatal life. In this study the adenosine A2A receptor agonist CGS21680 was used to evaluate adenosine receptor specificity and the interrelation of adenosine and GABA in the inhibition of inspiratory drive. In neonatal piglets (n = 10), CGS21680 was injected into the fourth ventricle resulting in apnea and/or decreased burst area and frequency of phrenic discharge. Phrenic burst area decreased to 58.9 ± 8.6% (S.E.M.) after CGS21680 injection (control = 91.8 ± 1.0%). Expiratory time increased 261.0 ± 59.9% after CGS21680 from control (87.7 ± 2.7%). When bicuculline was injected locally within the rostral ventrolateral medulla (n = 5), or into the fourth ventricle (n = 5), the CGS21680 induced inhibition of phrenic was abolished. To define expression of A2A receptor at the message level (mRNA), we employed in situ hybridization with a digoxigenin-coupled oligonucleotide. Adenosine A2A receptor mRNA was expressed in regions of the medulla oblongata known to contain GABAergic neurons. We conclude that GABAergic inputs affecting respiratory timing and inspiratory drive are modulated by activation of A2A receptors. These findings offer new insight into the mechanism whereby xanthine therapy diminishes apnea of prematurity. © 2004 Elsevier B.V. All rights reserved.
KW - Development, respiratory inhibition
KW - Mammals, Piglet
KW - Pharmacological agents, A receptor agonist CGS21680
KW - Receptor, A, GABA
KW - Ventilation, drive, inhibition by GABA, adenosine
KW - Pharmacological agents, A2A receptor agonist CGS21680
KW - Receptor, A2A, GABA A
UR - http://www.scopus.com/inward/record.url?scp=3042698668&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=3042698668&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/edc87222-a874-313d-835b-cd70b75e81e1/
U2 - 10.1016/j.resp.2004.04.012
DO - 10.1016/j.resp.2004.04.012
M3 - Article
C2 - 15239970
SN - 1569-9048
VL - 141
SP - 201
EP - 211
JO - Respiratory Physiology and Neurobiology
JF - Respiratory Physiology and Neurobiology
IS - 2
ER -